Apellis Pharmaceuticals Inc Beta
Cos'è Beta di Apellis Pharmaceuticals Inc?
Beta di Apellis Pharmaceuticals Inc è 1.38
Qual è la definizione di Beta?
BETA indica se una azione è più o meno volatile rispetto al mercato nel suo complesso. Un beta inferiore a 1 indica che la azione è meno volatile rispetto al mercato, mentre un beta più di 1 indica che la azione è più volatile. La volatilità è misurata come la fluttuazione del prezzo attorno alla media.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta di aziende nel Health Care settore su NASDAQ rispetto a Apellis Pharmaceuticals Inc
Cosa fa Apellis Pharmaceuticals Inc?
apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.
Aziende con beta simili a Apellis Pharmaceuticals Inc
- TE Connectivity ha Beta di 1.38
- Manitou BF SA ha Beta di 1.38
- Beter Bed N.V ha Beta di 1.38
- LGB Forge ha Beta di 1.38
- Jubilant Industries ha Beta di 1.38
- Sportech Plc ha Beta di 1.38
- Apellis Pharmaceuticals Inc ha Beta di 1.38
- Rocky Mountain Dealerships ha Beta di 1.38
- United Community Banks ha Beta di 1.38
- Linamar ha Beta di 1.38
- Linamar ha Beta di 1.38
- ODP ha Beta di 1.38
- CESC ha Beta di 1.38